Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in protein

Patterson, JR; Hirst, WD; Howe, JW; Russell, CP; Cole-Strauss, A; Kemp, CJ; Duffy, MF; Lamp, J; Umstead, A; Kubik, M; Stoll, AC; Vega, IE; Steece-Collier, K; Chen, Y; Campbell, AC; Nezich, CL; Glajch, KE; Sortwell, CE

Patterson, JR (通讯作者),Michigan State Univ, Dept Translat Neurosci, Grand Rapids, MI 49503 USA.

NPJ PARKINSONS DISEASE, 2022; 8 (1):

Abstract

beta 2-adrenoreceptor (beta 2AR) agonists have been associated with a decreased risk of developing Parkinson's disease (PD) and are hypothesized to de......

Full Text Link